BIONDI MARTA

Pievani, A., Biondi, M., Tettamanti, S., Biondi, A., Dotti, G., Serafini, M. (2024). CARs are sharpening their weapons. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 12(1) [10.1136/jitc-2023-008275]. Dettaglio

Biondi, M., Tettamanti, S., Galimberti, S., Cerina, B., Tomasoni, C., Dotti, G., et al. (2023). Overexpression of CXCR4 receptor on CD33.CAR-CIK cells enhances the control of the Acute Myeloid Leukemia burden. Intervento presentato a: 5th European CAR T-cell meeting, Virtual, online. Dettaglio

Biondi, M., Tettamanti, S., Galimberti, S., Cerina, B., Tomasoni, C., Piazza, R., et al. (2023). Selective homing of CAR-CIK cells to the bone marrow niche enhances control of the Acute Myeloid Leukemia burden. BLOOD, 141(21), 2587-2598 [10.1182/blood.2022018330]. Dettaglio

(2022). Enhancing AML CAR CIK therapeutic potency increasing the localization of engineered cells in the malignant niche and its selectivity by LSCs specific targeting. (Tesi di dottorato, Università degli Studi di Milano-Bicocca, 2022). Dettaglio

Biondi, M., Cerina, B., Tomasoni, C., Dotti, G., Tettamanti, S., Biondi, A., et al. (2022). Improving Bone Marrow Homing and Persistence of CD33.CAR-CIK Cells By Overexpression of a Gain-of-Function Variant of CXCR4 to Increase Efficacy in Acute Myeloid Leukemia. Intervento presentato a: 2nd Translational Research Conference IMMUNE & CELLULAR THERAPIES, Berlino. Dettaglio